Literature DB >> 8391025

Subclass-specific serum antibody responses to recombinant Norwalk virus capsid antigen (rNV) in adults infected with Norwalk, Snow Mountain, or Hawaii virus.

J J Treanor1, X Jiang, H P Madore, M K Estes.   

Abstract

Subclass-specific antibody responses to the Norwalk virus capsid protein in adults challenged with Norwalk, Snow Mountain, or Hawaii virus were evaluated by solid-phase enzyme immunoassay using recombinant Norwalk virus capsid antigen (rNV). Fourfold or greater serum immunoglobulin G (IgG) antibody responses to rNV were detected in 15 of 20 volunteers challenged with Norwalk virus, and serum IgA and IgM antibody responses to rNV were seen in almost all subjects who had rNV IgG responses. Serum rNV IgG antibody responses also were detected in 6 of 15 volunteers challenged with Snow Mountain virus and 2 of 12 volunteers challenged with the Hawaii virus. However, the magnitude of antibody response and the geometric mean postchallenge rNV IgG antibody titers were lower in subjects challenged with Snow Mountain or Hawaii virus, and serum IgA and IgM responses generally did not occur.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8391025      PMCID: PMC265593          DOI: 10.1128/jcm.31.6.1630-1634.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  Antigenic relationships between human caliciviruses and Norwalk virus.

Authors:  W D Cubitt; N R Blacklow; J E Herrmann; N A Nowak; S Nakata; S Chiba
Journal:  J Infect Dis       Date:  1987-11       Impact factor: 5.226

2.  Antigenic relatedness among the Norwalk-like agents by serum antibody rises.

Authors:  H P Madore; J J Treanor; R Buja; R Dolin
Journal:  J Med Virol       Date:  1990-10       Impact factor: 2.327

3.  Antigenic characterization of small, round-structured viruses by immune electron microscopy.

Authors:  S Okada; S Sekine; T Ando; Y Hayashi; M Murao; K Yabuuchi; T Miki; M Ohashi
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

4.  Serum immunoglobulin A response to Norwalk virus infection.

Authors:  D D Erdman; G W Gary; L J Anderson
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

5.  Development and evaluation of an IgM capture enzyme immunoassay for diagnosis of recent Norwalk virus infection.

Authors:  D D Erdman; G W Gary; L J Anderson
Journal:  J Virol Methods       Date:  1989 Apr-May       Impact factor: 2.014

6.  Western blot (immunoblot) assay of small, round-structured virus associated with an acute gastroenteritis outbreak in Tokyo.

Authors:  Y Hayashi; T Ando; E Utagawa; S Sekine; S Okada; K Yabuuchi; T Miki; M Ohashi
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

7.  Norwalk virus genome cloning and characterization.

Authors:  J N Xi; D Y Graham; K N Wang; M K Estes
Journal:  Science       Date:  1990-12-14       Impact factor: 47.728

8.  Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults.

Authors:  P C Johnson; J J Mathewson; H L DuPont; H B Greenberg
Journal:  J Infect Dis       Date:  1990-01       Impact factor: 5.226

9.  Development of an enzyme immunoassay for the Hawaii agent of viral gastroenteritis.

Authors:  J J Treanor; H P Madore; R Dolin
Journal:  J Virol Methods       Date:  1988-12       Impact factor: 2.014

10.  Production of a monoclonal antibody against the Snow Mountain agent of gastroenteritis by in vitro immunization of murine spleen cells.

Authors:  J Treanor; R Dolin; H P Madore
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

View more
  30 in total

1.  Identification of Aichi virus infection by measurement of immunoglobulin responses in an enzyme-linked immunosorbent assay.

Authors:  T Yamashita; M Ito; H Tsuzuki; K Sakae
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

2.  Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens.

Authors:  Anne M Hutson; Robert L Atmar; Donald M Marcus; Mary K Estes
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 3.  Porcine enteric caliciviruses: genetic and antigenic relatedness to human caliciviruses, diagnosis and epidemiology.

Authors:  Qiu-Hong Wang; Veronica Costantini; Linda J Saif
Journal:  Vaccine       Date:  2006-12-29       Impact factor: 3.641

Review 4.  Viral gastroenteritis: small round structured viruses, caliciviruses and astroviruses. Part I. The clinical and diagnostic perspective.

Authors:  E O Caul
Journal:  J Clin Pathol       Date:  1996-11       Impact factor: 3.411

5.  Expression and self-assembly of recombinant capsid protein from the antigenically distinct Hawaii human calicivirus.

Authors:  K Y Green; A Z Kapikian; J Valdesuso; S Sosnovtsev; J J Treanor; J F Lew
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

6.  An epidemiological investigation of Norwalk virus infection in South Africa.

Authors:  M B Taylor; S Parker; W O Grabow; W D Cubitt
Journal:  Epidemiol Infect       Date:  1996-04       Impact factor: 2.451

7.  Identification of cross-reactive norovirus CD4+ T cell epitopes.

Authors:  Anna D LoBue; Lisa C Lindesmith; Ralph S Baric
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

8.  Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge.

Authors:  Anna D LoBue; Joseph M Thompson; Lisa Lindesmith; Robert E Johnston; Ralph S Baric
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

9.  Exposure to human and bovine noroviruses in a birth cohort in southern India from 2002 to 2006.

Authors:  Vipin Kumar Menon; Santosh George; Aruna A Shanti; Anuradha Saravanabavan; Prasanna Samuel; Sasirekha Ramani; Mary K Estes; Gagandeep Kang
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

Review 10.  Norovirus immunology: Of mice and mechanisms.

Authors:  Kira L Newman; Juan S Leon
Journal:  Eur J Immunol       Date:  2015-08-25       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.